These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17512352)

  • 21. [What is current status? Current status in the primary therapy of advanced ovarian cancer].
    du Bois A
    Krankenpfl J; 1999; 37(1-2):32-4. PubMed ID: 10401374
    [No Abstract]   [Full Text] [Related]  

  • 22. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
    Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
    Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of current diagnosis and treatment in ovarian cancer.
    Mould T
    Int J Gynecol Cancer; 2012 May; 22 Suppl 1():S2-4. PubMed ID: 22543914
    [No Abstract]   [Full Text] [Related]  

  • 24. [Statistical review of ovarian tumor].
    Terashima Y; Ochiai K; Sasaki H
    Nihon Rinsho; 1993 Jan; 51 Suppl():799-813. PubMed ID: 8459616
    [No Abstract]   [Full Text] [Related]  

  • 25. Oncology today: ovarian cancer.
    Tiedemann D
    RN; 2000 Oct; 63(10):36-41; quiz 42. PubMed ID: 11062665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment.
    Aletti GD; Podratz KC; Cliby WA; Gostout BS
    Gynecol Oncol; 2009 Jan; 112(1):22-7. PubMed ID: 18947860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Second-line chemotherapy of ovarian cancer].
    de Gramont A; Drolet Y; Lavoie A; Painchaud M; Blouin R; Tessier C; Ouellet P
    Union Med Can; 1984 Nov; 113(11):940-2. PubMed ID: 6516049
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cancer of the ovary].
    Lhomme C; Slagmulder N; Bussy C; Lopez C; Droz JP
    Rev Infirm; 1991 Nov; 41(17):39-43. PubMed ID: 1767221
    [No Abstract]   [Full Text] [Related]  

  • 29. Observations on the interpretation of clinical trials in early ovarian cancer.
    Swart AM; Parmar MK
    J Clin Oncol; 2005 Feb; 23(4):927; author reply 937-8. PubMed ID: 15681549
    [No Abstract]   [Full Text] [Related]  

  • 30. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study.
    Fagotti A; Paris I; Grimolizzi F; Fanfani F; Vizzielli G; Naldini A; Scambia G
    Gynecol Oncol; 2009 Jun; 113(3):335-40. PubMed ID: 19345401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intraperitoneal chemotherapy for ovarian cancer].
    Noma J; Yoshida N
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Torpid course of recurrent ovarian cancer (2 cases)].
    Abragam KA
    Vopr Onkol; 1984; 30(6):104-6. PubMed ID: 6741003
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ovarian cancer from the standpoint of medical oncology].
    Kato Y; Katsumata N
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1017-21. PubMed ID: 17637538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian cancer: an overview of treatment options.
    Martin VR
    Clin J Oncol Nurs; 2007 Apr; 11(2):201-7. PubMed ID: 17573269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cancer drugs on survival: often poorly evaluated.
    Prescrire Int; 2009 Aug; 18(102):180-3. PubMed ID: 19746577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
    Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
    Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of recurrent ovarian cancer successfully treated with adoptive immunotherapy and lentinan.
    Fujimoto K; Tomonaga M; Goto S
    Anticancer Res; 2006; 26(6A):4015-8. PubMed ID: 17195451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.